In future studies, dual inhibitors of both the IGF1R and the IR are preferably chosen because it has been shown in osteoblasts [48] and Ewing sarcoma cells [49] that cells can circumvent inhibition of IGF1R by increasing IR signalling. The gene discussed is IGF1R; the disease is Ewing sarcoma.